{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:54:31Z","timestamp":1786550071137,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/ajg.2016.304","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T08:22:50Z","timestamp":1470126170000},"page":"1428-1436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study"],"prefix":"10.14309","volume":"111","author":[{"given":"Halima","family":"Cheddani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Dauchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathurin","family":"Fumery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clo\u00e9","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Dupas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Savoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Gower-Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210210","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/gut.2003.025346","article-title":"Opposite evolution in incidence of Crohns disease and ulcerative colitis in Northern France (1988-1999).","volume":"53","author":"Molinie","year":"2004","journal-title":"Gut"},{"key":"R2-19-20210210","first-page":"3","article-title":"Inflammatory bowel disease in the elderly.","volume":"11","author":"Stein","year":"2006","journal-title":"Arizona Geriat Soc"},{"key":"R3-19-20210210","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases.","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"key":"R4-19-20210210","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/gutjnl-2012-303864","article-title":"Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study.","volume":"63","author":"Charpentier","year":"2014","journal-title":"Gut"},{"key":"R5-19-20210210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.crohns.2010.08.004","article-title":"IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008.","volume":"5","author":"Lakatos","year":"2011","journal-title":"J Crohn Colitis"},{"key":"R6-19-20210210","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.","volume":"126","author":"Rutter","year":"2004","journal-title":"Gastroenterology"},{"key":"R7-19-20210210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ijc.28346","article-title":"Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data.","volume":"134","author":"Nieminen","year":"2014","journal-title":"Int J Cancer"},{"key":"R8-19-20210210","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1136\/gutjnl-2011-300953","article-title":"Colitis-associated cancer: the dark side of inflammatory bowel disease.","volume":"60","author":"Danese","year":"2011","journal-title":"Gut"},{"key":"R9-19-20210210","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/gut.37.5.674","article-title":"A controlled double blind study of azathioprine in the management of Crohns disease.","volume":"37","author":"Candy","year":"1995","journal-title":"Gut"},{"key":"R10-19-20210210","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/apt.13466","article-title":"Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.","volume":"43","author":"Bourrier","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"R11-19-20210210","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7326\/0003-4819-123-2-199507150-00009","article-title":"Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis.","volume":"123","author":"Pearson","year":"1995","journal-title":"Ann Intern Med"},{"key":"R12-19-20210210","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohns disease: the ACCENT I randomised trial.","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"R13-19-20210210","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohns disease.","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"R14-19-20210210","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199502023320503","article-title":"Methotrexate for the treatment of Crohns disease. The North American Crohns Study Group Investigators.","volume":"332","author":"Feagan","year":"1995","journal-title":"N Engl J Med"},{"key":"R15-19-20210210","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM200006013422202","article-title":"A comparison of methotrexate with placebo for the maintenance of remission in Crohns disease. North American Crohns Study Group Investigators.","volume":"342","author":"Feagan","year":"2000","journal-title":"N Engl J Med"},{"key":"R16-19-20210210","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mnm.0000169205.21377.6a","article-title":"Inflammatory bowel diseases: clinical update of practical guidelines.","volume":"26","author":"Viscido","year":"2005","journal-title":"Nucl Med Commun"},{"key":"R17-19-20210210","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis.","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"R18-19-20210210","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","article-title":"Human anti-tumor ne-crosis factor monoclonal antibody (adalimumab) in Crohns disease: the CLASSIC-I trial.","volume":"130","author":"Hanauer","year":"2006","journal-title":"Gastroenterology"},{"key":"R19-19-20210210","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohns disease: the CHARM trial.","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"key":"R20-19-20210210","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"R21-19-20210210","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2011.06.050","article-title":"Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.","volume":"141","author":"Peyrin-Biroulet","year":"2011","journal-title":"Gastroenterology"},{"key":"R22-19-20210210","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"R23-19-20210210","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cgh.2013.04.033","article-title":"Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis.","volume":"12","author":"Singh","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R24-19-20210210","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0531-5565(92)90011-N","article-title":"Overview of cancer and aging: a mechanistic perspective.","volume":"27","author":"Hart","year":"1992","journal-title":"Exp Gerontol"},{"key":"R25-19-20210210","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMra0804615","article-title":"DNA damage, aging, and cancer.","volume":"361","author":"Hoeijmakers","year":"2009","journal-title":"N Engl J Med"},{"key":"R26-19-20210210","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1273::AID-CNCR13>3.0.CO;2-4","article-title":"Cancer burden in the aged.","volume":"80","author":"Yancik","year":"1997","journal-title":"Cancer"},{"key":"R27-19-20210210","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1136\/gut.35.10.1433","article-title":"Incidence of inflammatory bowel disease in northern France (1988-1990).","volume":"35","author":"Gower-Rousseau","year":"1994","journal-title":"Gut"},{"key":"R28-19-20210210","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.dld.2012.09.005","article-title":"Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD).","volume":"45","author":"Gower-Rousseau","year":"2013","journal-title":"Dig Liver Dis"},{"key":"R29-19-20210210","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"R30-19-20210210","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12885-015-1168-2","article-title":"Total and partial cancer prevalence in the adult French population in 2008; French Network of Cancer Registries (FRANCIM).","volume":"15","author":"Colonna","year":"2015","journal-title":"BMC Cancer"},{"key":"R32-19-20210210","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/ajg.2009.760","article-title":"Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies.","volume":"105","author":"Pedersen","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R33-19-20210210","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study.","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"key":"R34-19-20210210","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish Population-Based Cohort Study.","volume":"108","author":"Jess","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R35-19-20210210","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1053\/j.gastro.2013.07.035","article-title":"Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.","volume":"145","author":"Khan","year":"2013","journal-title":"Gastroenterology"},{"key":"R36-19-20210210","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"key":"RU37-19-20210210","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.cgh.2013.06.023","article-title":"Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.","volume":"11","author":"Rubin","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R38-19-20210210","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2013.03.044","article-title":"Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.","volume":"145","author":"Beaugerie","year":"2013","journal-title":"Gastroenterology"},{"key":"R39-19-20210210","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/MIB.0b013e318286f771","article-title":"Adenomas in patients with inflammatory bowel disease are associated with an increased risk of advanced neoplasia.","volume":"19","author":"Van Schaik","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"R40-19-20210210","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ajg.2010.428","article-title":"The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.","volume":"106","author":"Baars","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R41-19-20210210","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2036.2006.02854.x","article-title":"Meta-analysis: colorectal and small bowel cancer risk in patients with Crohns disease.","volume":"23","author":"Canavan","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R42-19-20210210","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A population-based study.","volume":"323","author":"Ekbom","year":"1990","journal-title":"N Engl J Med"},{"key":"R43-19-20210210","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis.","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"R44-19-20210210","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cgh.2009.11.024","article-title":"Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.","volume":"8","author":"Long","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R45-19-20210210","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.","volume":"143","author":"Long","year":"2012","journal-title":"Gastroenterology"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2016304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2016304","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2016304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201610000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:13:14Z","timestamp":1786547594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201610000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2016.304","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}